Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors
Metrics: PDF 1263 views | HTML 3072 views | ?
Margarida Ferreira-Teixeira1,2, Belmiro Parada1,3, Paulo Rodrigues-Santos4,5,6, Vera Alves5,6, José S. Ramalho7, Francisco Caramelo8, Vitor Sousa9,10, Flávio Reis1,2,6, Célia M. Gomes1,2,6
1Laboratory of Pharmacology and Experimental Therapeutics, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
2CNC.IBILI, University of Coimbra, Coimbra, Portugal
3Urology and Renal Transplantation Department, Coimbra University Hospital Centre (CHUC), Coimbra, Portugal
4Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal
5Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
6Center of Investigation in Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
7CEDOC, Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal
8Laboratory of Biostatistics and Medical Informatics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
9Institute of Anatomical and Molecular Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
10Service of Anatomical Pathology, Coimbra University Hospital Centre (CHUC), Coimbra, Portugal
Célia M. Gomes, e-mail: email@example.com
Keywords: bladder cancer, cancer stem cells, ALDH, stemness markers, chemoresistance
Received: May 22, 2015 Accepted: September 24, 2015 Published: October 05, 2015
Striking evidence associates cancer stem cells (CSCs) to the high recurrence rates and poor survival of patients with muscle-invasive bladder cancer (BC). However, the prognostic implication of those cells in risk stratification is not firmly established, mainly due to the functional and phenotypic heterogeneity of CSCs populations, as well as, to the conflicting data regarding their identification based on a single specific marker. This emphasizes the need to exploit putative CSC-related molecular markers with potential prognostic significance in BC patients.
This study aimed to isolate and characterize bladder CSCs making use of different functional and molecular approaches. The data obtained provide strong evidence that muscle-invasive BC is enriched with a heterogeneous stem-like population characterized by enhanced chemoresistance and tumor initiating properties, able to recapitulate the heterogeneity of the original tumor. Additionally, a logistic regression analysis identified a 2-gene stem-like signature (SOX2 and ALDH2) that allows a 93% accurate discrimination between non-muscle-invasive and invasive tumors.
Our findings suggest that a stemness-related gene signature, combined with a cluster of markers to more narrowly refine the CSC phenotype, could better identify BC patients that would benefit from a more aggressive therapeutic intervention targeting CSCs population.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.